Professor Tammy Steeves, School of Biological Sciences, University of Canterbury, comments: “Colossal–a 10-billion dollar biotechnology company that ... technologies to save endangered birds. We can ...

He then shared the logo that features joyful Shiba Inu holding US flag in his hand, drawing attention of none other than Ramaswamy. “‘Omg super cute!!’” one X user wrote. “I never ...

The suit alleges the Seattle-based biotech misled investors regarding its funds and the effectiveness of some of its treatment candidates. Seattle-based Sana Biotechnology Inc. (Nasdaq ...

A U.S. congressional commission has made the case for “swift action” to maintain the nation’s role as a biotech superpower, while warning the sector is “dangerously close to falling behind ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t want to lose to China, warns a national security commission made up ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating funding for an Atlanta biotech’s lead COVID-19 vaccine program that’s ...

Legend Biotech has no tariff exposure and manufactures Carvykti entirely in the U.S. for both U.S. and EU markets. HC Wainwright maintains a $75 target, citing Carvykti’s strong efficacy and ...

Investors' deep pessimism is actually bullish, and less regulatory constraint could fuel new drug approval and M&A Biotech is one of the U.S. stock market's most unloved sectors. But several ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...